Pfizer: Innovative Oral Treatment Options for Patients

Pfizer Cordially Invites You to Attend An Informational Program

Innovative Oral Treatment Options for Patients: HR+/HER2- MBC or gBRCA-Mutated TNBC and HR+/HER2- MBC

Featuring
RENA CALLAHAN, MD
Assistant Clinical Professor of Medicine University of California Los Angeles

Please RSVP to your Pfizer Representative
Joyce Lew

Kindly provide your full name, degree, specialty, address including state, and email address when registering so that you can be confirmed. Please also provide the Meeting ID#INT-0047364 when you RSVP.